179 related articles for article (PubMed ID: 32468131)
1. Risk factors of impairment of shoulder function after axillary dissection for breast cancer.
Kikuuchi M; Akezaki Y; Nakata E; Yamashita N; Tominaga R; Kurokawa H; Hamada M; Aogi K; Ohsumi S; Tsuji T; Sugihara S
Support Care Cancer; 2021 Feb; 29(2):771-778. PubMed ID: 32468131
[TBL] [Abstract][Full Text] [Related]
2. The effects of poloxamer and sodium alginate mixture (Guardix-SG®) on range of motion after axillary lymph node dissection: A single-center, prospective, randomized, double-blind pilot study.
Lee SB; Gwark SC; Kang CM; Sohn G; Kim J; Chung IY; Lee JW; Kim HJ; Ko BS; Ahn SH; Kim W; Do J; Jeon JY; Kim J; Um E; Yoon TI; Jung SU; Han M; Son BH
PLoS One; 2020; 15(9):e0238284. PubMed ID: 32966294
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.
Kootstra JJ; Dijkstra PU; Rietman H; de Vries J; Baas P; Geertzen JH; Hoekstra HJ; Hoekstra-Weebers JE
Breast Cancer Res Treat; 2013 May; 139(1):125-34. PubMed ID: 23588950
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection.
Akezaki Y; Nakata E; Kikuuchi M; Tominaga R; Kurokawa H; Hamada M; Aogi K; Ohsumi S; Sugihara S
Breast Cancer; 2020 Mar; 27(2):284-290. PubMed ID: 31679113
[TBL] [Abstract][Full Text] [Related]
5. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
[TBL] [Abstract][Full Text] [Related]
6. Winged scapula incidence and upper limb morbidity after surgery for breast cancer with axillary dissection.
Rizzi SK; Haddad CA; Giron PS; Pinheiro TL; Nazário AC; Facina G
Support Care Cancer; 2016 Jun; 24(6):2707-15. PubMed ID: 26800686
[TBL] [Abstract][Full Text] [Related]
7. Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer.
Voogd AC; Ververs JM; Vingerhoets AJ; Roumen RM; Coebergh JW; Crommelin MA
Br J Surg; 2003 Jan; 90(1):76-81. PubMed ID: 12520579
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of a self-administered, home-based exercise rehabilitation program for women following a modified radical mastectomy and axillary node dissection: a preliminary study.
Kilgour RD; Jones DH; Keyserlingk JR
Breast Cancer Res Treat; 2008 May; 109(2):285-95. PubMed ID: 17624606
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study.
Beurskens CH; van Uden CJ; Strobbe LJ; Oostendorp RA; Wobbes T
BMC Cancer; 2007 Aug; 7():166. PubMed ID: 17760981
[TBL] [Abstract][Full Text] [Related]
10. Axillary web syndrome after axillary dissection in breast cancer: a prospective study.
Torres Lacomba M; Mayoral Del Moral O; Coperias Zazo JL; Yuste Sánchez MJ; Ferrandez JC; Zapico Goñi A
Breast Cancer Res Treat; 2009 Oct; 117(3):625-30. PubMed ID: 19306057
[TBL] [Abstract][Full Text] [Related]
11. Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome.
Marazzi F; Masiello V; Marchesano D; Boldrini L; Luzi S; Ferrara PE; Amabile E; Piccari D; Landi F; Moschella F; Franceschini G; Masetti R; Mantini G; Valentini V; Smaniotto D
Tumori; 2019 Aug; 105(4):319-330. PubMed ID: 30935295
[TBL] [Abstract][Full Text] [Related]
12. Shoulder Strength Changes One Year After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Patients With Breast Cancer.
Monleon S; Ferrer M; Tejero M; Pont A; Piqueras M; Belmonte R
Arch Phys Med Rehabil; 2016 Jun; 97(6):953-63. PubMed ID: 26763950
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for seroma formation after axillary lymph node dissection with special focus on the impact of early shoulder exercise.
Borg G; Dihge L; Johansson K
Acta Oncol; 2023 May; 62(5):444-450. PubMed ID: 37129993
[TBL] [Abstract][Full Text] [Related]
14. Manual therapy associated with upper limb exercises vs. exercises alone for shoulder rehabilitation in postoperative breast cancer.
Pace do Amaral MT; Freire de Oliveira MM; Ferreira Nde O; Guimarães RV; Sarian LO; Gurgel MS
Physiother Theory Pract; 2012 May; 28(4):299-306. PubMed ID: 22007656
[TBL] [Abstract][Full Text] [Related]
15. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
16. The perioperative educational program for improving upper arm dysfunction in patients with breast cancer: a controlled trial.
Sato F; Ishida T; Ohuchi N
Tohoku J Exp Med; 2014 Feb; 232(2):115-22. PubMed ID: 24561542
[TBL] [Abstract][Full Text] [Related]
17. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
[TBL] [Abstract][Full Text] [Related]
18. Immediate versus delayed shoulder exercises after axillary lymph node dissection.
Jansen RF; van Geel AN; de Groot HG; Rottier AB; Olthuis GA; van Putten WL
Am J Surg; 1990 Nov; 160(5):481-4. PubMed ID: 2240381
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of exercise programmes on shoulder mobility and lymphoedema after axillary lymph node dissection for breast cancer: systematic review.
Chan DN; Lui LY; So WK
J Adv Nurs; 2010 Sep; 66(9):1902-14. PubMed ID: 20626480
[TBL] [Abstract][Full Text] [Related]
20. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
